REG - ConvaTec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

20/10/2020 16:05

RNS Number : 6911C
  
ConvaTec Group PLC
  
20 October 2020
  
 

20 October 2020
ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 30 September 2020, Mr Karim Bitar, Chief Executive Officer and a PDMR, received 1,124,095 Shares following the vesting of a share award made to him under the Company's Long term Incentive Plan ("LTIP") in September 2019. On 1 October 2020, Mr Bitar sold 529,782 shares at £1.808 per share to cover the income tax liabilities relating to the vesting of the share award, leaving a retained balance of 594,313 Shares. The vesting of the award made under the LTIP was not subject to any performance conditions other than continued employment. 
Further, on 15 October 2020, Mr Bitar acquired 7338 Shares at £1.775 per share under the terms of the Dividend Reinvestment Plan ("DRP") operated by the Company's registrars for employees holding shares within its Share Plan Account. 
Mr Bitar's resulting shareholding is 1,606,064 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail. 
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Karim Bitar




2


Reason for the notification




a)


Position/Status


Chief Executive Officer




b)


Initial notification/Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


ConvaTec Group Plc




b)


LEI


213800LS272L4FIDOH92




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a) 


Description of the financial instrument, type of instrument 
Identification code


Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73




b) 


Nature of the transaction


Sale of shares arising from the exercise of the share award which vested on 30 September 2020, to offset income tax and social security liabilities on the exercise.




c) 


Price(s) and volume(s)


Price(s)
1.808
 


Volume(s)
529,782




d)


Aggregated information
- Aggregated volume  
- Price


 
N/A
N/A




e)


Date of the transaction


1 October 2020




f)


Place of the transaction


London Stock Exchange, Main Market (XLON)




 
 




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Karim Bitar




2


Reason for the notification




a)


Position/Status


Chief Executive Officer




b)


Initial notification/Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


ConvaTec Group Plc




b)


LEI


213800LS272L4FIDOH92




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a) 


Description of the financial instrument, type of instrument 
Identification code


Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73




b) 


Nature of the transaction


Acquisition of Shares under the terms of the Dividend 
Reinvestment Plan operated by the Company's registrars for employees holding shares within its Share Plan Account.
 




c) 


Price(s) and volume(s)


Price(s)
1.775
 


Volume(s)
7338




d)


Aggregated information
- Aggregated volume  
- Price


 
N/A
N/A




e)


Date of the transaction


15 October 2020




f)


Place of the transaction


Outside a trading venue




 
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations & 
Corporate Communications, ConvaTec,                                              +44 (0)7826 447807
ir@convatec.com
 
Media
Buchanan: Charles Ryland / Chris Lane                                              +44 (0)207 466 5000                                                                                                         
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFESITLIFII